Gabelli & Co Investment Advisers’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-260,106	Closed	-$2.19M	–	192
2015 Q4	$2.19M	Buy	+260,106	New	+$1.74M	0.26%	58

Gabelli & Co Investment Advisers's OCAT Position: Q1 2016 in Review

Gabelli & Co Investment Advisers sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 260,106 shares — an estimated $2.19M sold.

Gabelli & Co Investment Advisers first reported a position in OCAT in Q4 2015 and held it in 1 quarter. The position peaked at $2.19M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

Gabelli & Co Investment Advisers reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 260,106 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $2.19M.
Gabelli & Co Investment Advisers first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
Gabelli & Co Investment Advisers's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $2.19M in Q4 2015.
1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2016, filed 5 May 2016.